Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nangia-Makker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|February 23, 2011
Galectin-3 binding and metastasisP Nangia-Makker, Y Honjo, A Raz
Cancer Metastasis Reviews|February 24, 2001
Carbohydrate-recognition and angiogenesisP Nangia-Makker, S Baccarini, A Raz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cellsY Honjo, P Nangia-Makker, H Inohara, et al.
Cancer Research|October 15, 1993
Regulation of the expression of galactoside-binding lectin during human monocytic differentiationP Nangia-Makker, J Ochieng, J K Christman, et al.
Cell Death & Disease|March 4, 2011
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatmentY Wang, P Nangia-Makker, V Balan, et al.
Cancer Research|December 11, 1997
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 familyS Akahani, P Nangia-Makker, H Inohara, et al.
Oncogene|November 20, 2012
Galectin-3 regulates p21 stability in human prostate cancer cellsY Wang, V Balan, D Kho, et al.
The American Journal of Pathology|March 7, 2000
Galectin-3 induces endothelial cell morphogenesis and angiogenesisP Nangia-Makker, Y Honjo, R Sarvis, et al.
Breast Cancer Research and Treatment|August 8, 1998
Galectin-3 and L1 retrotransposons in human breast carcinomasP Nangia-Makker, R Sarvis, D W Visscher, et al.
The American Journal of Pathology|May 20, 1998
Direct action of estrogen on sequence of progression of human preneoplastic breast diseaseM P Shekhar, P Nangia-Makker, S R Wolman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|February 23, 2011
Galectin-3 binding and metastasisP Nangia-Makker, Y Honjo, A Raz
Cancer Metastasis Reviews|February 24, 2001
Carbohydrate-recognition and angiogenesisP Nangia-Makker, S Baccarini, A Raz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cellsY Honjo, P Nangia-Makker, H Inohara, et al.
Cancer Research|October 15, 1993
Regulation of the expression of galactoside-binding lectin during human monocytic differentiationP Nangia-Makker, J Ochieng, J K Christman, et al.
Cell Death & Disease|March 4, 2011
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatmentY Wang, P Nangia-Makker, V Balan, et al.
Cancer Research|December 11, 1997
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 familyS Akahani, P Nangia-Makker, H Inohara, et al.
Oncogene|November 20, 2012
Galectin-3 regulates p21 stability in human prostate cancer cellsY Wang, V Balan, D Kho, et al.
The American Journal of Pathology|March 7, 2000
Galectin-3 induces endothelial cell morphogenesis and angiogenesisP Nangia-Makker, Y Honjo, R Sarvis, et al.
Breast Cancer Research and Treatment|August 8, 1998
Galectin-3 and L1 retrotransposons in human breast carcinomasP Nangia-Makker, R Sarvis, D W Visscher, et al.
The American Journal of Pathology|May 20, 1998
Direct action of estrogen on sequence of progression of human preneoplastic breast diseaseM P Shekhar, P Nangia-Makker, S R Wolman, et al.
Pageof 2